Meridian Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Meridian Wealth Management's NVO Position: Q1 2026 in Review
Meridian Wealth Management reduced its Novo Nordisk (NVO) stake by 72% in Q1 2026, selling an estimated $1.57M and leaving 13,145 shares worth $483K. The position accounts for 0.02% of the portfolio, ranked #526.
Meridian Wealth Management first reported a position in NVO in Q2 2019 and has held it in 16 quarters since. The position peaked at $15.1M in Q3 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Meridian Wealth Management held 13,145 shares of Novo Nordisk worth $483K as of Q1 2026.
- Meridian Wealth Management sold 33,190 Novo Nordisk shares in Q1 2026, an estimated $1.57M.
- Novo Nordisk made up 0.02% of Meridian Wealth Management's portfolio in Q1 2026, its #526 holding.
- Meridian Wealth Management first reported a position in Novo Nordisk in Q2 2019 and has held it in 16 quarters since.
- Meridian Wealth Management's Novo Nordisk position peaked at $15.1M in Q3 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Meridian Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.